Current Challenges in Fragment-Based Drug Discovery
Roderick E Hubbard, University of York, speaking at Discovery Chemistry Congress 2012.
An Open Innovation Ecosystem for Drug Discovery
Dr Michael Barnes, OI Pharma Partners Ltd., speaking at Discovery Chemistry Congress 2012.
Rationalizing ADME in the Current Regulatory and Business Environment
Robert Guttendorf, Aclairo Pharmaceutical Development Group, speaking at ADME & Predictive Toxicology Europe
In Vitro, Ex Vivo and in Models to Develop New Therapies for Renal Diseases
Frederick W. K. Tam, Imperial College London, speaking at ADME & Predictive Toxicology Europe 2012
Biotransformation: Still a Bottleneck for in Vitro Kinetic and Dynamic Approaches
Sandra Coecke, European Centre for the Validation of Alternative Methods, speaking at ADME & Predictive Toxicology Europe
In Silico Toxicology: Where are We at and Where are We Going?
John C. Dearden, Liverpool John Moores University, speaking at ADME & Predictive Toxicology Europe 2012
Functional Interrogation of 'omics' Data
Dr Kartiki V Desai, National Insitute of Biomedical Genomics, speaking at Screening Asia 2011.
Utilising Informatics to Add Value to Banked Samples
Jane Rogan, Manchester Cancer Research Centre Biobank, speaking at World Biobanking Summit 2011.
State-of-the-Art in Ligand-Based Virtual Screening
Jürgen Bajorath, Professor, Department of Life Science Informatics, University of Bonn, speaking at Medchem Europe 2011.
|<< || 1 2 3 4 5 6 || >>|
|Showing Results 31 - 40 of 56|